ADDITIVE CARDIOVASCULAR RISK REDUCTION OF GLP1A AND SGLT2I IN DIABETIC PATIENTS WITH ATHEROSCLEROTIC DISEASE

被引：0
|
作者：
Loyo, Persio Lopez
Bohra, Chandrashekar
Bhatia, Kirtipal
Baruch, Lawrence
Eng, Calvin
机构：
[1] James J Peters VA Med Ctr, New York, NY USA
[2] Mt Sinai Morningside, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1430 / 1430
页数：1
相关论文
共 50 条
  • [41] ECONOMIC BURDEN OF DIABETIC PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CARDIOVASCULAR DISEASE OR RISK FACTORS FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Marcellusi, A.
    Sciattella, P.
    Bini, C.
    Rotundo, M.
    Aimaretti, G.
    Mennini, F. S.
    VALUE IN HEALTH, 2020, 23 : S509 - S509
  • [42] The Risk of Cardiovascular (CV) Events After Initiation of SGLT2i, GLP-1RA, DPP4i, or SUs in Patients With T2D and Low-to-Moderate CV Risk
    Tesfaye, Helen
    Paik, Julie M.
    Alix, Caroline
    DiCesare, Elyse C.
    Cromer, Sara J.
    Everett, Brendan M.
    Glynn, Robert J.
    Wexler, Deborah J.
    Patorno, Elisabetta
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 86 - 87
  • [43] Risk of Urogenital Infections in Patients with Type 2 Diabetes Initiating SGLT2i Versus GLP-1RA: A Danish Emulated Target Trial
    Ljungberg, Christine
    Kristensen, Frederik P. B.
    Dalager-Pedersen, Michael
    Vandenbroucke-Grauls, Christina
    Norgaard, Mette
    Thomsen, Reimar W. W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 46 - 46
  • [44] Impact of SGLT2i on cardiovascular outcomes and heart failure in patients with type 2 diabetes
    Jose Rodriguez, Juan
    Ortega-Paz, Luis
    Brugaletta, Salvatore
    Sabate, Manel
    AIMS MEDICAL SCIENCE, 2018, 5 (01): : 67 - 79
  • [45] SGLT2i Use and the Risk of Nephrolithiasis in Patients with T2D
    Paik, Julie M.
    Tesfaye, Helen
    Curhan, Gary
    Mastrorilli, Julianna M.
    Wexler, Deborah J.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [46] Genetic Mimics of GLP-1Ra and SGLT2i Therapy, Heart Failure and Chronic Kidney Disease Outcomes
    Remala, Subbaramireddy
    Liang, Liming
    Shah, Amil
    Buckley, Leo
    CIRCULATION, 2024, 150
  • [47] Impact of Endocrine E-Consultation on SGLT2i and GLP-1 RA Prescription
    Rasheed, Amna
    Kompala, Tejaswi
    Neinstein, Aaron B.
    DIABETES, 2021, 70
  • [48] Taking position: Effect of SGLT2i on arterial pressure, vascular damage, kidney disease and associated cardiovascular risk
    Inserra, Felipe
    Forte, Ezequiel
    Elbert, Alicia
    Waisman, Gabriel
    Castellaro, Carlos
    Buso, Carlos
    Fairman, Enrique
    Cobo, Augusto Lavalle
    Manucha, Walter
    Salmeri, Emiliano
    Sanabria, Hugo
    Sanchez, Ramiro
    Terns, Paula Perez
    Aranguren, Florencia
    Arias, Pablo
    Castano, Yanina
    De Marziani, Guillermo
    Faingold, Cristina
    Gonzalez, Joaquin
    Jawerbaum, Alicia
    Vazquez, Fabiana
    Wappner, Diego
    Zaidel, Ezequiel J.
    Aiello, Ernesto A.
    Alfie, Jose
    De Cerchio, Alejandro
    Choi, Marcelo
    Marquez, Diego
    Piskorz, Daniel
    Pupi, Luis Maria
    Renna, Nicolas
    Salazar, Martin
    Dorado, Enrique
    Ferder, Leon
    Lavenia, Gustavo
    Orias, Marcelo
    Paganti, Luciana Gonzalez
    Rigo, Diego H.
    Diez, Guillermo Rosa
    Sivak, Leonardo
    Trimarchi, Hernan
    Majul, Claudio
    Sinay, Isaac
    Marin, Marcos
    Bonanno, Carlos
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2024, 44 (02): : 49 - 51
  • [49] Mitochondrial insights on antidiabetic therapies: Differential impacts of SGLT2i, GLP-1, and insulin
    Lin, Yu-Hsiang
    Chang, Kuo-Hsuan
    Lu, Yu-Jen
    PHARMACOLOGICAL RESEARCH, 2025, 212
  • [50] Role of SGLT2 Inhibitors and GLP-1 Analogs in Cardiovascular Risk Reduction in Type 2 Diabetes
    Rashed, Mostafa Hamdy
    Dauyoumor, Tonbra Deborah
    Corney, Sarah
    Konono, Kimberly
    Joubert, Nadia
    Mohamed, Marwa
    Sukhoo-Pertab, Michon
    Makhomisane, Mobowa
    Njeri, Irene
    Mwita, Julius
    Sefen, Mariam
    Mohamed, Khadija
    Whiley, Nicolette
    WORLD FAMILY MEDICINE, 2021, 19 (12): : 119 - 128
12345